A new brain imaging study has revealed that lysergic acid diethylamide (LSD) alters brain connectivity in ways that are ...

A copy of the Company’s poster will be available under the Scientific Presentations tab of the Tonix website at www.tonixpharma.com following the conference. Additional meeting information can be ...

Of the 103 patients who completed the Phase III trial, more than half saw remission from a drug-induced condition.

Company expects to have sufficient cash to fund planned operations beyond the FDA PDUFA goal date and anticipated fourth quarter 2025 launch of TNX-102 SL for fibromyalgia; $98.8 million in cash as of ...

It was 13:30 in the afternoon when the Manhattan police station received one dramatic report: the body of Barbara Weinstein ...

Department of Pharmacy, Quaid-i-Azam University, Islamabad 45320, Pakistan Department of Chemistry, Quaid-i-Azam University, Islamabad 45320, Pakistan ...

Persson, T., and Roos, B.-E., Lancet, ii, 987 (1967). Coppen, A., Shaw, D. M., Herzberg, B., and Maggs, R., Lancet, ii, 1178 (1967). Sjoerdsma, A., Oates, J. A ...

Mathew B, Haridas A, Uçar G, Baysal I, Adeniyi AA, Soliman ME, et al.. Exploration of Chlorinated Thienyl Chalcones: A New Class of Monoamine Oxidase-B Inhibitors. International Journal of Biological ...

Announcing a new publication for Acta Materia Medica journal. Monoamine oxidase (MAO) is a useful target in the treatment of neurodegenerative diseases and depressive disorders. Understanding the ...

Despite being "less likely to experience unpleasant or unpredictable effects" whilst drinking alcohol while taking an SSRI or a serotonin-noradrenaline reuptake inhibitor (SNRI) antidepressant, they ...